Sign Up to like & get
recommendations!
1
Published in 2017 at "Neuropsychopharmacology"
DOI: 10.1038/npp.2017.263
Abstract: Sponsorship Statement: Publication of this supplement is sponsored by the ACNP. Individual contributor disclosures may be found within the abstracts. Part 1: All Financial Involvement with a pharmaceutical or biotechnology company, a company providing clinical…
read more here.
Keywords:
annual meeting;
part;
years 2014;
company ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Neuropsychopharmacology"
DOI: 10.1038/npp.2017.264
Abstract: Sponsorship Statement: Publication of this supplement is sponsored by the ACNP. Individual contributor disclosures may be found within the abstracts. Part 1: All Financial Involvement with a pharmaceutical or biotechnology company, a company providing clinical…
read more here.
Keywords:
annual meeting;
part;
years 2014;
company ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.20210121
Abstract: OBJECTIVE The aim was to determine the epidemiological profile of dengue fever in Brazil between the years 2014 and 2019. METHODS This is an observational, descriptive, cross-sectional, and retrospective study, which was carried out through…
read more here.
Keywords:
brazil years;
years 2014;
2014 2019;
profile dengue ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.820757
Abstract: Introduction It is well acknowledged that the price of orphan drugs is normally higher than that resulting from the value-based pricing. A correlation between the cost of therapy for orphan drugs and the epidemiology (prevalence…
read more here.
Keywords:
epidemiology;
orphan drugs;
therapy;
cost ... See more keywords